The expansion of brain size is accompanied by a relative enlargement of the subventricular zone during development. Epithelial-like neural stem cells divide in the ventricular zone at the ventricles of the embryonic brain, self-renew and generate basal progenitors 1 that delaminate and settle in the subventricular zone in enlarged brain regions 2 . The length of time that cells stay in the subventricular zone is essential for controlling further amplification and fate determination. Here we show that the interphase centrosome protein AKNA has a key role in this process. AKNA localizes at the subdistal appendages of the mother centriole in specific subtypes of neural stem cells, and in almost all basal progenitors. This protein is necessary and sufficient to organize centrosomal microtubules, and promote their nucleation and growth. These features of AKNA are important for mediating the delamination process in the formation of the subventricular zone. Moreover, AKNA regulates the exit from the subventricular zone, which reveals the pivotal role of centrosomal microtubule organization in enabling cells to both enter and remain in the subventricular zone. The epithelialto-mesenchymal transition is also regulated by AKNA in other epithelial cells, demonstrating its general importance for the control of cell delamination.
. We chose to examine AKNA because levels of Akna mRNA correlate with the time at which the subventricular zone (SVZ) is generated (that is, low at embryonic day (E)11, high at E14 and low at E18), and because neural stem cells (NSCs) isolated at the peak of SVZ generation have higher levels of Akna when transitioning to basal progenitors 3 (Extended Data Fig. 1a, b) . To investigate the function of AKNA, we first generated monoclonal antibodies, which were validated by RNA interference Methods) . Given the annotation of AKNA as an AT-hook transcription factor 6 , we were surprised to find specific immunofluorescence signals at centrosomes (Fig. 1a, in different cell types of various species 8, 10) , which was confirmed by BAC-transgenic cell lines (Extended Data Fig. 1h ) and fractionation of cell lysates (Extended Data Fig. 1n, o) . Ultrastructural analysis showed that AKNA largely localized to the distal part of the subdistal appendages (SDAs) of the mother centriole in interphase; some AKNA was also found at the proximal ends of centrioles and along microtubules (Extended Data Fig. 2a Fig. 2i ) and the SDA protein ODF2 (Extended Data Fig. 2j, k) . AKNA localizes to the centrosome through its carboxy terminal part-a region that was omitted from its first description 6 (see Supplementary Discussion)-as AKNA(1-1080), which lacks the C-terminal 324 amino acids, is distributed in the cytoplasm but is still able to bind to microtubules (Extended Data Fig. 2l , which is consistent with higher levels of Akna mRNA in this population 9 (Extended Data Fig. 4g, h ). Thus, AKNA exhibits an unprecedented subtype specificity, being restricted to the centrosomes of differentiating NSCs and basal progenitors in forebrain development.
Knockdown of AKNA, mediated by short hairpin (sh)RNA, (Extended Data Fig. 1d ) via in utero electroporation (IUE) in E13 cortices led to the retention of GFP + cells in the ventricular zone with more self-renewing (PAX6 
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Supplementary Video 4). This phenotype was observed with two different shRNAs, was rescued by co-electroporating AKNA ( f, j, Box plots show median, quartiles (box) and range (whiskers). e, Control shRNA, n = 6; Akna shRNA no. 1, n = 5; Akna shRNA no. 2 (shAkna 2), n = 5 embryos. *P ≤ 0.05, **P ≤ 0.01 (exact P values (from top to bottom) 0.00796, 0.00432, 0.00865, 0.02217, 0.03174, 0.01731, 0.00432, 0.00865 and 0.00865). f, Control shRNA, n = 5; Akna shRNA no. 2, n = 5 embryos. NS, not significant, **P ≤ 0.01 (exact P values (from left to right) 0.00793, 0.30952 and 0.00793). i, GFP (control), n = 9; AKNA overexpression, n = 11; AKNA(1-1080), n = 4 embryos. **P ≤ 0.01, ***P ≤ 0.001 (exact P values (from top to bottom) 0.00779, 0.00147 and 0.00008). j, GFP (control), n = 4; AKNA overexpression, n = 4 embryos. NS, not significant, *P ≤ 0.05 (exact P values (from left to right), 0.02857, 0.48571 and 0.02857). e, f, i, j, Two-sided Mann-Whitney U test. Scale bars, 2.5 μm (a), 20 μm (b), 50 μm (c, d, g, h). shRNA control, n = 110; Akna shRNA no. 2, n = 92 microtubule endpoints from 4 independent experiments each (P = 0.00007). d, AKNA overexpression clusters organize microtubules independently of centrosomes (see also Extended Data Fig. 6b ) (n = 6). e, Most GFP + electroporated cells lose their integration into the apical cadherin belt at the ventricle (V) 18 h after AKNA overexpression (n = 3 embryos).
f, Line graph illustrating the distribution of GFP + cells 24 h after IUE. Mean ± s.e.m. as transparent band in the same colour. GFP (control), n = 9; AKNA overexpression, n = 11; AKNA and E-cadherin (E-CAD) overexpression, n = 3 embryos. GFP (control) and AKNA overexpression is based on the same data as shown in Fig. 1i . *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001 (exact P values (from top to bottom) 0.02597, 0.00779, 0.00909 and 0.00008). g, h, En face view of ventricular endfeet in E14 cortex delineated by ZO-1 (g), quantified in h, showing the inverse correlation of AKNA immunofluorescence intensity and endfoot size. Transparent band depicts the best-fit curve with the 95% confidence interval (n = 76 cells from 4 embryos). i, Dot and violin plot (dots represent individual cells, mean ± s.e.m. in bold in the centre) depicting the reduced size of the apical endfeet after AKNA overexpression. GFP (control), n = 76 cells; AKNA overexpression, n = 14 cells; n = 4 embryos each; P = 0.00339. b, c, f, i, Two-sided Mann-Whitney U test. Scale bars, 5 μm. not occur in vitro (Extended Data Fig. 5l) , and is therefore due to the altered niche that is encountered upon delamination in vivo. Live imaging in cortical slices showed that AKNA overexpression accelerated NSC delamination by a retraction of the apical processes without cell division (28% (n = 33) compared to 3% (n = 165) in controls) (Supplementary Video 5). Thus, AKNA-induced delamination occurs in interphase, during which AKNA localizes at centrosomes. Consistent with this, overexpression of AKNA(1-1080) hardly increased delamination (Fig. 1i) , which indicates the importance of the centrosomal localization of this protein.
Given the function of SDAs 10 in microtubule organization, we tested whether AKNA regulates microtubule organization using nocodazole-based microtubule regrowth assays (Extended Data  Fig. 6a ). shRNA-mediated AKNA knockdown in primary cortical cells resulted in a significant reduction in the number of cells with centrosomal microtubule regrowth, and of microtubule-fibre length (Fig. 2a-c) . Independently of centrosomes, microtubule asters emanated from ectopic AKNA bodies upon AKNA overexpression (Fig. 2d) in an apparently size-dependent manner (Extended Data Fig. 6b ). Importantly, AKNA efficiently recruited components of the γ-tubulin ring complex (γTuRC), such as TUBG and GCP4, as well as CKAP5 (also known as ch-TOG) (the mammalian homologue of the microtubule nucleator and polymerase XMAP215 11 ), but not other centrosome-and microtubule-associated proteins (Extended Data Fig. 6c, d) ; this demonstrates the specificity of γTuRC and microtubule nucleation factor recruitment, and how AKNA affects microtubule nucleation and growth. AKNA also recruits and co-immunoprecipitates with SDA proteins that are involved in microtubule organization such as EB1 (also known as MAPRE1), DCTN1 (also known as P150-Glued), dynein and ODF2 12,13 (Extended Data Fig. 6e, f) . AKNA is thus a novel regulator of the centrosome, controlling microtubule organizing centre (MTOC) activity specifically in differentiating NSCs. Notably, AKNA does not affect cilia formation or length in NSCs, despite its localization at SDAs (Extended Data Fig. 7a-d) .
Interestingly, CAMSAP3-a microtubule minus-end binding protein-was recruited to AKNA + foci (Extended Data Fig. 6e ). Consistent with CAMSAP proteins anchoring non-centrosomal microtubules at epithelial junctions 14 , CAMSAP3 was enriched at the NSC junctions at the ventricular surface (Extended Data Fig. 7e ), and cadherin levels at the apical surface were reduced after AKNA overexpression (Fig. 2e) . However, maintaining high levels of cadherin with AKNA and E-cadherin co-IUE was not sufficient to interfere with the AKNAinduced delamination process (Fig. 2f) . At the junctions surrounding the apical endfoot at the ventricular surface, microtubule and actin belts mediate abscission 15 . High levels of AKNA at the centrosome correlated with a smaller size of apical endfeet, delineated by ZO-1 immunostaining (Fig. 2g, h ), and AKNA overexpression increased the number of cells with small endfeet (Fig. 2i) . Thus, AKNA regulates the delamination process by increasing centrosomal MTOC activity, weakening junctional complexes and promoting contraction of the apical endfoot.
As AKNA also binds directly to microtubules, we monitored microtubule dynamics by EB3-GFP live imaging in cortex slices after IUE in vivo. EB3-GFP comets grew mostly in a basal direction in NSCs after GFP IUE, as previously shown 16 ; however, after AKNA overexpression, comets displayed more random directions (Extended Data Fig. 8a , b, Supplementary Videos 6, 7), which indicates a change in the orientation of microtubule growth and a repositioning of the MTOC toward non-apical positions (see schematic in Extended Data Fig. 7j ). AKNA overexpression also had minor effects on the speed of EB3-GFP comets (Extended Data Fig. 8c ). To determine possible direct effects of AKNA on microtubules, we reconstituted microtubules in a centrosome-free environment in vitro. The presence of AKNA affected growth velocity but not microtubule lifetime (Extended Data Fig. 8d -f, Supplementary Video 2). Moreover, once a depolymerizing microtubule encountered a site of AKNA enrichment, the depolymerization velocity was significantly reduced (Extended Data Fig. 8g , Supplementary Video 2), which demonstrates that AKNA affects microtubule dynamics in vivo and in vitro. These dynamics are important for delamination, as stabilizing microtubules using Taxol in vivo blocked the AKNA-induced delamination (Extended Data Fig. 8h ).
As the delamination from the ventricular zone resembles the epithelial-mesenchymal transition (EMT) [17] [18] [19] , we asked whether AKNA is more generally relevant for EMT by monitoring normal murine mammary gland (NMuMG) epithelial cells during EMT induced by transforming growth factor beta-1 (TGFβ1) 20, 21 . Centrosomal AKNA levels are low in untreated NMuMG cells, but upregulated early in EMT (Extended Data Fig. 8i-k) . As expected 14 , NMuMG cells show largely non-centrosomal microtubule polymerization before EMT (Supplementary Video 8), and AKNA overexpression increased microtubule nucleation at the centrosome (Extended Data Fig. 8l , Supplementary Video 9). Knockdown of AKNA using small interfering (si)RNAs (Extended Data Fig. 8m ) had no effect on the expression of core EMT transcription factors Twist1, Zeb2, Snai1 and Snai2 during EMT (Extended Data Fig. 8i ), but led to ZO-1 retention at cell junctions and counteracted the TGFβ1-induced disassembly of these junctions Extended Data Fig. 8o, p) . AKNA knockdown also attenuated the rearrangement of actin fibres from the junctions to stress fibres ( Fig. 3a-c) , showing the importance of AKNA in fully dissolving these junctional complexes during EMT. Immunostaining confirmed that AKNA is sufficient to significantly reduce CAMSAP3 at the junctional interface closest to AKNA + foci upon overexpression, but not CAMSAP3 at more-distant junctions (Fig. 3e , f, Extended Data Fig. 8q ). Conversely, AKNA knockdown resulted in the retention of CAMSAP3 at cell junctions after TGFβ1-induced EMT (Fig. 3g , Extended Data . NS, not significant, ***P ≤ 0.001 (exact P values (from left to right) 5.2 × 10 −6 , 0.93189 and 0.00004). f, g, Dot and box plots showing significant reduction in CAMSAP3 at the cell junction close to AKNA foci after AKNA overexpression (position 1 in the micrograph in e) but not in EMT with Akna siRNA. In f, untransfected, n = 26 cells; AKNA overexpression: n = 22 cells, from 3 independent experiments. P = 0.00003. In g, untreated, n = 42 cells; TGFβ1-treated and control siRNA, n = 51 cells; TGFβ1-treated and Akna siRNA, n = 50 cells, from 3 independent experiments. NS, not significant, ***P ≤ 0.001 (exact P values (from left to right) 0.00086, 0.75728 and 0.00095). d, f, g, Twosided Mann-Whitney U test; box plots show median, quartiles (box) and range (whiskers). Scale bars, 10 μm. Fig. 8r ). Thus, AKNA mediates the remodelling of junctional complexes by recruiting CAMSAP3 from junctional microtubules to the centrosome, thereby destabilizing junctional cadherins 22 and enabling cells to detach during EMT.
Besides the role of AKNA in the EMT-like delamination of NSCs, we aimed to determine its function within the SVZ, the region with highest levels of AKNA (only 10% of centrosomes were AKNA + above the SVZ in the cortical plate where neurons are located) (Extended Data Fig. 4e ). Accordingly, neurons isolated in vitro showed a greater degree of non-centrosomal microtubule polymerization (Extended Data Fig. 9a, b) , as compared to NSCs. To counteract the reduction in levels of AKNA above the SVZ, we expressed Akna cDNA under the late basal progenitor and neuron-specific doublecortin (Dcx) promoter (Extended Data Fig. 9c ) at E13. This resulted in many GFP + cells remaining below the cortical plate, as compared to control ( Fig. 4a-d ), without affecting proliferation at two days post-electroporation (Fig. 4e ) or neuronal differentiation (Extended Data Fig. 9d-f) . Conversely, Dcx-promoter-driven Akna microRNAs (miRNAs) did not affect cells that left the SVZ and reached normal positions within the cortical plate, similar to controls (Extended Data Fig. 9g, h ). Thus, the downregulation of AKNA that occurs physiologically (Fig. 1b,  Extended Data Fig. 4d, e, g ) facilitates the transition of neurons from the SVZ to the cortical plate.
To determine at which step AKNA levels are critical in the transition from multipolar SVZ cells to bipolar neurons migrating into the cortical plate 23 (schematic in Extended Data Fig. 7i ), we performed live imaging in slices after AKNA overexpression or knockdown in vivo. Control and knockdown cells had similar migratory speeds during locomotion (Fig. 4f) , but knockdown cells transitioned faster from the multipolar SVZ morphology to the bipolar morphology of migrating neurons (Fig. 4g, h ). Conversely, many cells with AKNA overexpression retained a multipolar morphology and migrated less frequently (Fig. 4i, j, Supplementary Video 10) . Thus, AKNA is key not only in bringing cells into the SVZ but also in retaining them there. These data provide further support for the suggestion that the switch to bipolar morphology and radial neuronal migration requires a switch from a centrosomal to more non-centrosomal MTOC via endogenous downregulation of AKNA. Indeed, the mutant, non-centrosome-localizing form of AKNA (that is, AKNA(1-1080)) expressed under the Dcx promoter failed to retain cells in the SVZ (Fig. 4a-c) , which highlights the importance of the centrosomal location of AKNA in this process of morphology switching and migration.
In neurons, microtubules originate preferentially from other non-centrosomal compartments 24 , allowing axon and dendrite formation 25, 26 , and have more stable detyrosinated and acetylated microtubules 27, 28 . AKNA counteracts these neuronal hallmarks by promoting centrosomal microtubule nucleation, faster microtubule growth, and more dynamic and less detyrosinated microtubules (Extended Data Fig. 8m, n) . Therefore, the downregulation of AKNA is required for neurons to migrate into the cortical plate. Thus, microtubule organization differs profoundly for cell migration into the SVZ, which requires AKNA and a centrosomal MTOC, versus migration out of the SVZ, which requires the loss of AKNA.
During the delamination process, AKNA orchestrates the disassembly of junctional complexes as well as apical endfoot constriction. As microtubule stabilization by Taxol blocked the AKNA-induced delamination, microtubule dynamics and rearrangement are critical. Moreover, the centrosomal localization of AKNA is important, as the non-centrosomal form, AKNA(1-1080), showed impaired delamination but could still bind microtubules. AKNA increased centrosomal microtubule nucleation by recruiting γTuRC and CKAP5
11 . Thistogether with the low-level direct binding of AKNA to microtubulesexplains why AKNA gain of function both promotes nucleation and inhibits depolymerization. AKNA recruits CAMSAP3 to the centrosome. This microtubule minus-end binding protein otherwise tethers microtubules to the adherens junctions 14 contributing to adherens junction stability 22 and cell-cell attachment 29 . Thus, AKNA orchestrates the delamination process by increasing centrosomal microtubule nucleation and recruiting nucleation factors and minus-end stabilizers, thereby destabilizing microtubules at the adherens junctions and mediating constriction of the apical endfoot. The recruitment of AKNA to the centrosome is post-translationally regulated; SOX4 regulates Akna mRNA in EMT 21 and the generation of basal progenitors 30 (Extended Data Fig. 10a-c) . Regulating AKNA levels orchestrates delamination and retention in the SVZ-this process is particularly relevant in species with highly proliferative cells 2 in an enlarged SVZ (Extended Data Fig. 10d-r) . Thus, the function of AKNA in ontogeny may have profound relevance in phylogeny.
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Extended Data Fig. 1 | AKNA expression, centrosome localization and  antibody verification. a, Quantitative PCR with reverse transcription (RTqPCR) data show higher levels of Akna mRNA in E14 cerebral cortex than in E11 or E18 cerebral cortex (n = 3 biologically independent samples, mean ± s.e.m., one-way ANOVA with Tukey's post hoc test. b, Microarray data depicting higher expression of AKNA in NSCs that generate basal progenitors (CD133 + , hGFAP-GFP high (transgenic mice expressing GFP under control of the human GFAP promoter) 3 (hGFAP-GFP, n = 4; hGFAP-GFP low , n = 3 independent samples, mean ± s.e.m., two-sided Student's t-test, note that all GFAP-GFP + cells were double-stained for CD133 prior to FACS (see ref.
3 ). c, Western blot of AKNA in E14 cerebral cortex lysate running at a higher-than-predicted (153 kDa) molecular mass, owing to phosphorylation (data not shown, see also Extended Data Fig. 3d) (n = 8 independent experiments) . d, e, Western blot of AKNA in Neuro2a cell lysates after transfection with Akna shRNA no. 1, Akna shRNA no. 2 or control shRNA (d, n = 2 independent experiments) or 3 different miRNAs and control (e, 1 experiment), using the antibody clone 14D7. f, AKNA immunofluorescence using clone 25F1 in primary E14 cortical cells, which show TBR2 + basal progenitors that lack AKNA immunofluorescence signal upon transfection with Akna siRNAs but not with control siRNA, demonstrating the specificity of the immunostaining (n = 3 independent experiments). g, Immunofluorescence of AKNA and TUBG in primary E14 cortical cells, showing AKNA signal surrounding a single TUBG + centriole (n > 10 independent experiments). h, A20 BAC transgenic cell line showing GFP-tagged AKNA at centrosomes marked by TUBG in interphase (h′ and h′′′) but not during mitosis (h′′) (n = 3 independent experiments). i, Predicted domains of mouse AKNA protein. j, Amino acid sequence of AT-hook-containing transcription-factor domain of AKNA, and of the AT-hook-like domain. Note that AKNA lacks the GRP core sequence surrounded by several K and R amino acids, which is required for DNA-or RNA-binding AT-hook domains (such as the AT-hook domains of HMGA1). k-m, Immunostaining of dissociated cerebral organoid cells derived from human induced pluripotent stem cells (hiPSCs), showing AKNA localization at centrosomes with 3 different monoclonal antibodies (n = 2 independent experiments each). Clone 9G1 and 4F5 recognize epitopes in the N-and C-terminal parts of the protein, respectively, which suggests that different splice variants 6,31 still localize at centrosomes. One (mother) centriole is enriched for AKNA. n, Western blot of AKNA in nuclear and cytoplasmic cell fractions of A20 cells, showing AKNA signal in the cytoplasm only (n = 2 independent experiments). o, Mass spectrometric analysis of sucrose-gradient-based isolated cellular sub-fractions of A20 cells. AKNA is enriched in fractionsExtended Data Fig. 2 | Mechanisms of AKNA localization.  a, b , Electron microscopy micrographs showing AKNA immunogoldlabelling at SDAs in the SVZ (a) and ventricular zone (b) of E13 cerebral cortex sections; b′, a magnification of the boxed area showing an SDA in b (n = 3 embryos). c, Stimulated emission depletion nanoscopy image showing AKNA immunofluorescence signal surrounding ODF2 immunofluorescence signal; this reveals the more-distal localization of AKNA at the SDA, as compared to ODF2, which localizes proximally with respect to the centriole in E14 brain NSCs (summarized in the schematic below; AKNA, green, ODF2, magenta) (n = 2 independent experiments). d, Micrographs showing DNA points accumulation for imaging in nanoscale topography super-resolution images of AKNA and TUBA, illustrating that AKNA is present along microtubules in E14 cortical cells (n = 3 independent experiments). e, Coomassie staining of a sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) gel showing samples of purified in vitro polymerized tubulin, with and without addition of purified recombinant AKNA as indicated (n = 2 independent experiments). Note that full-length AKNA coprecipitates with polymerized tubulin (lane 4), showing that AKNA is able to bind microtubules in vitro. f-h, E14 primary cortical cells treated with DMSO (f), nocodazole (g) or DCTN2 overexpression (h) show AKNA immunofluorescence remaining at centrosomes after microtubule depolymerization (n = 4 (f, g) and 3 (h) independent experiments). i, Micrographs showing AKNA immunofluorescence signal at centrosomes at the apical, ventricular surface in sections of E14 wild-type, but not
Sas4
−/− p53 −/− (Sas4 is also known as Cenpji, and p53 is also known as Trp53) mice that lack centrioles 7 (n = 2 independent experiments). Note that PCNT + pericentriolar material is present in the absence of centrioles in Sas4 −/− p53 −/− mice. j, k, AKNA immunofluorescence of wild-type (j) or CRISPR-Cas9-generated Odf2 knock-out (k) mammary epithelial cells, showing that AKNA is lost from centrioles lacking SDAs (n = 3 independent experiments each). l, Schematic of different truncated AKNA variants used to analyse sub-cellular localization, as indicated to the right. m, n, Micrographs showing examples of the localization of truncated AKNA forms expressed in primary E14 cortical cells. Constructs containing the last 370 amino acids (n) localize to centrosomes, whereas AKNA(1-1080) is not localized at the centrosome (square) and is mainly cytoplasmic (m) (n = 3 independent experiments each). Notably, the clone used 6 to first characterize AKNA lacked the C-terminal centrosome-targeting part. o, Representative images obtained from total internal reflection fluorescence (TIRF) time-lapse recordings of microtubules assembled in vitro from bovine brain tubulin, labelled with Cy5 in the presence of AKNA(1-1080)-GFP. BRB80 buffer with high salt concentration (100 mM KCl) was used to rule out unspecific binding to microtubules (n = 2 independent experiments). These data demonstrate that AKNA is an integral component of SDAs, is able to bind microtubules and is not recruited to centrosomes by microtubule or dynein-dynactin motors. Scale bars, 0.1 μm (a-c), 2 μm (d), 3 μm (o), 5 μm (f-h, m), 10 μm (i-k, n). Fig. 3 | AKNA dissociates from the centrosome during mitosis and upon increased phosphorylation. a, Immunofluorescence of AKNA in primary E14 cortical cells at different phases of the cell cycle, showing the lack of AKNA immunofluorescence at the centrosome during mitosis (n = 3 independent experiments). b, Western blot of AKNA in synchronized A20 cells, showing that AKNA protein is not degraded during mitosis (as indicated by the presence of phospho-histone H3) (n = 2 independent experiments). c, Representative micrographs of AKNA and PCNT immunofluorescence in E14 primary cortical cells treated with 500 nM okadaic acid (OA). Note that AKNA immunofluorescence is observed at centrosomes at 0 h but is undetectable in most cells 3 h after treatment, which shows that the centrosomal localization of AKNA is phosphorylation-dependent (n = 3 independent experiments). d, Western blot of lysates of OA-treated cells shows that phosphorylation-here caused by protein phosphatase inhibition-shifts that AKNA band on SDS-PAGE, and subsequently leads to protein degradation as observed in lysates of cells 5 h after OA washout (n = 3 independent experiments). Scale bars, 5 μm (a), 10 μm (c).
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Extended Data Fig. 4 | Temporal and sub-type-specific regulation of  AKNA in the developing telencephalon. a-c, Micrographs showing that PCNT + centrosomes lack AKNA in the cerebral cortex at E9 (a, n = 2 experiments) and E18 (b, n = 2 experiments), whereas AKNA is enriched in the ventricular zone and-specifically-the SVZ at E14 in the ganglionic eminence (c, n > 10 experiments) and the cerebral cortex (Fig. 1) . d, Distribution of AKNA + centrosomes in the E14 cortex (n = 3 independent experiments). e-g, Plots showing the percentage of AKNA + centrosomes in E14 and E13 cerebral cortex regions as indicated (e, f, n = 3 independent experiments), and in dissociated primary E14 cortical cells (g), which reveals that cells with AKNA + centrosomes are mostly differentiating NSCs (PAX6 + TBR2 + ) and PAX6 − TBR2 + basal progenitors (n = 3 independent experiments). EM, electron microscopy; IF, immunofluorescence. h, Micrographs of cells isolated from E14 cerebral cortex by FACS using prominin 1, and stained for PAX6 (red arrows) and TBR2 (blue arrows). This shows that double-positive (differentiating) NSCs have AKNA + centrosomes, whereas PAX6 + TBR2 − (proliferating) NSCs do not (n = 2 experiments). Data in d-g are presented as mean ± s.e.m. Scale bars, 10 μm (a, c, h), 20 μm (b).
Extended Data Fig. 5 | AKNA knock down elicits cell death, and  delamination defects persist upon cell-death rescue by p53 reduction. a, Confocal micrographs showing staining of E14 cortex one day after co-IUE of membrane-tagged mKO2 (monomeric Kusabira-Orange2) and cytoplasmic GFP. Note that the vast majority of cells electroporated with one plasmid also express the marker of the second plasmid (n = 4 embryos). b, Line graph illustrating the distribution of GFP + cells in the cerebral cortex after IUE for control shRNA (n = 6 embryos), Akna shRNA no. 1 (n = 5 embryos) and co-IUE of Akna shRNA and AKNA overexpression (0.2 μg μl −1 ) (n = 3 embryos). Note that the effect of AKNA knockdown is rescued with the appropriate amount of Akna expression, and is therefore specific. c-e, Micrographs showing TUNEL staining in E15 cerebral cortex, indicating cell death two days after IUE with Akna shRNA no. 1 (d, n = 3 embryos) or Akna shRNA no. 2 (d, n = 3 embryos) but not with control plasmids (c, n = 4 embryos). f, Dot and box plot showing the TUNEL + area per electroporated (GFP + ) area with control shRNA (n = 4 embryos) and Akna shRNA (n = 6 embryos, Akna shRNA no. 1 and Akna sRNA no. 2). g, h, Micrographs showing the distribution of GFP + cells in E15 cerebral cortex two days after IUE with control shRNA (g) or Akna shRNA no. 2 plus p53 miRNA plasmids (h). Note that p53 downregulation rescues the apoptotic effect of AKNA knockdown. i, Line graph illustrating the distribution of GFP + cells in the cerebral cortex after control shRNA (n = 6 embryos), p53 miRNA (n = 4 embryos), and Akna shRNA no. 2 and p53 miRNA (n = 4, embryos) IUE, showing the delamination defect that occurs upon AKNA knockdown is also present when apoptosis is blocked (Akna shRNA no. 2 and p53 miRNA). Note that p53 knockdown on its own does not alter the distribution of GFP + cells. j, Dot and box plot showing the decrease of GFP + TBR2 + cells after IUE of Akna shRNA-positive, p53 miRNA, as compared to control; this shows that defects in delamination are accompanied by retaining an NSC fate (control shRNA, n = 6; Akna shRNA no. 2 and p53 miRNA, n = 8 embryos). k, Dot and box plot showing a decrease in proliferating (KI67 + , n = 4 embryos each), and a concomitant increase in differentiated, NEUN + cells analysed at E14 after IUE at E13 (GFP, n = 3; AKNA overexpression, n = 5 embryos). l, Box plot showing the fraction of PAX6 + , KI67 + and NEUN + in E14 primary cortical cells 48 h after transfection in vitro (n = 3 embryos each). b, i, Line graphs show mean ± s.e.m. as a transparent band in the same colour; control shRNA and Akna shRNA no. 1 data in b and control shRNA in i are the same data as shown in Fig. 1e . Box plots show median, quartiles (box) and range (whiskers); b, f, i-k, two-sided Mann-Whitney U test; l, two-sided Students t-test. Scale bars, 50 μm.
Extended Data Fig. 6 | AKNA is sufficient to mediate microtubule polymerization and recruit γTuRC, CKAP5 and SDA components. a-e, Micrographs of E14 primary cortex cells treated and immunostained as indicated. a, Time series depicting regrowth of the microtubule cytoskeleton after nocodazole-mediated depolymerization (n = 3 experiments). b, Regrowth of the microtubules 60 s after nocodazolemediated depolymerization in AKNA overexpression (GFP + ) cells (n > 10 experiments). Red arrows indicate centrosomes. Note that microtubules polymerize also from ectopic AKNA + sites. c, Confocal images showing co-labelling of AKNA foci with the γTuRC components TUBG and GCP4, and microtubule nucleation factor CKAP5 (n = 2 experiments).
d, Confocal micrographs illustrating that AKNA foci fail to recruit PCNT, NEDD1 and the microtubule minus-end capping-proteins CAMSAP2, CEP170 and CLASP2 (n = 2 experiments). e, Confocal micrographs depicting co-localization of ectopic AKNA foci with ODF2, DCTN1, EB1, dynein and CAMSAP3 (n = 2 experiments; 4 experiments for CAMSAP3). f, Co-immunoprecipitation experiments with lysates from E14 cerebral cortex, immunoprecipitation with AKNA antibody and western blot with AKNA, ODF2, DCTN1, EB1 AND GCP2, showing that these proteins are in the same complex, except GCP2 (that is, γTuRC) (n = 2 independent experiments for each). Scale bars, 5 μm (a-e).
Extended Data Fig. 7 | AKNA effects on cilia formation or localization, the upstream regulation of Akna, and summary of AKNA effects. a, b, Histograms depicting the percentages of ciliated cells (ARL13 + ) (a, n = 4 independent experiments) and short versus long cilia (b, n = 4 independent experiments), in E14 primary cortical cells transfected with control shRNA or Akna shRNA. Short cilia are defined as dot-like (short axoneme or cilium not fully exposed to cell surface), and long cilia are defined as rod-shaped (long axoneme exposed at the cell surface). c, d, Integrated correlative light and electron microscopy micrographs of in utero-electroporated cells (n = 2 embryos). The images compare two neighbouring NSCs; one electroporated (blue) and one non-electroporated (orange). Yellow and pink arrows show anti-GFP and anti-TUBA immunogold signal in the cytoplasm and cilium of the electroporated cell. Notice that AKNA electroporation does not notably affect cilia formation in vivo. e, Confocal micrographs of CAMSAP3, CDH2 (N-cadherin) and F-actin staining in E14 cortex. i, Model describing the expression and functional role of AKNA in delamination and seeding of the SVZ. j. Schematic indicating and summarizing the modes of AKNA function in NSC delamination. Data in a, b are presented as mean ± s.e.m. Scale bars, 30 μm (c, immunofluorescence), 1 μm (c, electron microscopy), 0.1 μm (d), 25 μm (e).
Extended Data Fig. 8 | CAMSAP3 in the developing cortex, AKNA binding to and effects on purified microtubules, and AKNA regulation and function during EMT in mammary epithelial cells. a-c, AKNA overexpression in E14 cortex influences both the orientation (a, b, control, 117 EB3-comets; AKNA overexpression, 122 EB3-comets in 3 experiments; plot shows the distribution and solid line indicates the mean, ± s.e.m. as transparent band) and speed (c, control, 178 EB3-comets; AKNA overexpression, 113 EB3-comets) of microtubule polymerization monitored by live imaging of EB3-GFP in cortical slices 1 day after IUE. d, Representative kymographs obtained from TIRF timelapse images of microtubules assembled in vitro from bovine brain tubulin labelled with Cy5 in the presence of AKNA-GFP. Cy5 is shown in red and GFP in green. e-g, Dynamic instability parameters of microtubules assembled from bovine brain tubulin with and without AKNA. Tubulin concentration was 15 μM and AKNA concentration was 75 ng ml −1 . In reactions containing AKNA, the growth velocity was increased. Moreover, the mean depolymerization velocity of shrinking plus ends without an AKNA signal was 0.27 μm s −1 , and the mean velocity was 0.10 μm s −1 when AKNA was associated with the plus end (g). e, f, Microtubule, n = 117; microtubule and AKNA, 174; g, microtubule, n = 84; microtubule and AKNA, n = 47 single measurements made from 2 (microtubule) and 3 (microtubule and AKNA) independent experiments. h, Box plot showing marker expression 24 h after IUE of GFP (control) (n = 4 embryos), AKNA overexpression (n = 4 embryos) and AKNA overexpression supplemented with Taxol (20 μM) (n = 6 embryos). GFP (control) and AKNA overexpression is the same data as shown in Fig. 1j Fig. 3a) (untreated, n = 60 cells; TGFβ1-treated, control siRNA, n = 55 cells; TGFβ1-treatment, Akna siRNA, n = 76 cells; cell junctions = position 0). *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001 (exact P values (from left to right) 5.2 × 10 −6 , 0.00004 and 0.04177). q, Line graph depicting the quantification of CAMSAP3 intensity profiles across cells, as indicated in Fig. 3e (untransfected, n = 26 cells; AKNA overexpression, n = 22 cells). NS, not significant, ***P ≤ 0.001 (exact P values (from left to right) 0.53142 and 0.00003). r, Line graph depicting the quantification of CAMSAP3 intensity profiles across cells, as in Fig. 3e (untreated, n = 42 cells, TGFβ1-treated and control siRNA, n = 51 cells; TGFβ1-treated and Akna siRNA, n = 50 cells). *P ≤ 0.05, ***P ≤ 0.001 (exact P values (from left to right) 0.02478, 0.00038, 0.00095 and 0.00086). f-h, Box plots show median, quartiles (box) and range (whiskers). c, e, l, Violin plots show distribution of individual measurements (dots) with mean ± s.e.m. in bold in the centre (two-sided Mann-Whitney U test). Scale bars, 5 μm (j), 25 μm (a).
Extended Data Fig. 9 | Lower levels of AKNA in differentiating neurons mediate non-centrosomal microtubule polymerization and allow migration into the cortical plate. a, b, Primary E14 cortical cells were sorted for PROMININ 1 (CD133) to isolate NSCs or for PSA-NCAM to isolate neurons as indicated in the panels. PROM1
+ cells express the NSC marker nestin, whereas PSA-NCAM + cells express the neuronal marker TUBB3, showing the specificity of the FACS (a) (n = 2 independent experiments). Microtubule regrowth assay in purified NSCs shows centrosomal microtubule polymerization (b, top), and purified neurons show largely non-centrosomal microtubule polymerization patterns (b, bottom) (n = 2 independent experiments). c, Micrographs showing co-electroporation of a CAG-dsRED and DCX-GFP at E13 and analysis at E15. Note the onset of Dcx-GFP expression (c′′) only in the SVZ and cortical plate of the developing cortex, whereas DsRED + cells are also found in the ventricular zone (c, c′) (n = 3 embryos). d, e, Micrographs showing electroporated cells (GFP + ) in control (Dcx-GFP) (d) and Akna overexpressing (Dcx-Akna) (e) conditions (n = 3 embryos each conditions). Note that many AKNA overexpression cells accumulate in the SVZ, and are unable to migrate into the cortical plate. f, Micrographs of AKNA overexpression cells retained in the SVZ co-stained for TBR1, CTIP2, AND CUX1, which label neurons of different layer identity (n = 3 embryos). Note that the neuronal populations accumulating below the cortical plate upon Dcx-driven Akna expression contain neurons that are positive for each of these neuronal identities. g, Micrographs showing that electroporated cells (GFP + ) after control and Dcx-driven miRNA mediated downregulation of AKNA enter the cortical plate equally well (n = 3 embryos). h, Line graph illustrating the distribution of GFP The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement A statement on whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
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